Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › ME › Calais › NPI 1922001049
Hospital

Calais Community Hospital

Calais Community Hospital was paid $1.76M by Medicaid between Jan 2018 and Dec 2024, across 150 billing codes. Its largest line is 99285, emergency room visit (most serious) — 11% of everything it billed.

33Billing provider infoCALAIS COMMUNITY HOSPITAL
CALAIS, ME 04619
33aNPI1922001049assigned 05/23/2005
33bProvider typeCritical Access Hospital
28Total paid$1.76M
24GClaims276,131
24DCodes billed150
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Maine

Rank by total paid#8 of 14
Median peer was paid$1.76M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201841,705$298K
201944,084$263K
202037,130$226K
202137,983$220K
202237,211$243K
202341,544$254K
2024incomplete36,474$258K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 11% 5,420 4,156 $192K
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 11% 10,906 8,338 $185K
70450 Computed tomography, head or brain; without contrast material 10% 2,611 2,110 $178K
74177 Computed tomography, abdomen and pelvis; with contrast material 8.5% 1,729 1,433 $150K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.2% 15,477 11,872 $126K
71046 Radiologic examination, chest; 2 views 6.2% 6,035 4,336 $109K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4.9% 7,226 2,158 $87K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 4.2% 3,599 2,889 $74K
74176 Computed tomography, abdomen and pelvis; without contrast material 3.4% 570 474 $59K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.1% 4,585 3,909 $55K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 2.6% 6,390 5,242 $45K
71045 Radiologic examination, chest; single view 2.5% 2,652 2,257 $44K
138 more codes
71250 2.4% 515 $42K
96375 Therapeutic injection; each additional sequential IV push 1.8% 5,007 $32K
96361 Intravenous infusion, hydration; each additional hour 1.8% 3,214 $32K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.3% 9,300 $22K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.1% 4,523 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,399 $17K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 1,733 $16K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 3,717 $14K
72125 Computed tomography, cervical spine; without contrast material <1% 217 $14K
80053 Comprehensive metabolic panel <1% 17,440 $14K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,578 $13K
96376 <1% 1,824 $11K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 18,477 $11K
73560 <1% 537 $10K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 876 $9K
73030 <1% 469 $9K
99213 Doctor's office visit, returning patient (routine) <1% 2,003 $8K
20610 <1% 778 $7K
94060 <1% 346 $7K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 1,238 $7K
72100 <1% 231 $6K
94729 <1% 336 $6K
73630 <1% 629 $6K
84443 Thyroid stimulating hormone (TSH) <1% 4,436 $5K
94726 <1% 258 $5K
71275 Computed tomographic angiography, chest, with contrast material <1% 49 $5K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 1,290 $5K
83735 <1% 7,877 $5K
73610 <1% 518 $5K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 491 $4K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,421 $4K
84484 <1% 5,028 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,104 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 201 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 3,357 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 435 $3K
73502 <1% 127 $3K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 25 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 272 $3K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,611 $3K
36415 Collection of venous blood by venipuncture <1% 23,798 $3K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 136 $2K
97162 <1% 120 $2K
99214 Doctor's office visit, returning patient (more involved) <1% 429 $2K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 5,023 $2K
83880 <1% 1,994 $2K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 287 $2K
73110 <1% 175 $2K
82728 <1% 1,487 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,635 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 2,705 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 64 $1K
73130 <1% 107 $1K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 33 $1K
81000 <1% 3,627 $1K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 761 $1K
83605 <1% 2,952 $1K
83550 <1% 1,285 $1K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 1,613 $1K
87040 <1% 1,724 $1K
82803 <1% 1,897 $1K
83540 <1% 1,384 $1K
96367 <1% 176 $1K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 13 $1K
85610 <1% 3,523 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,573 $977.51
J2060 Injection, lorazepam, 2 mg <1% 534 $965.02
82607 <1% 990 $843.97
J1170 Injection, hydromorphone, up to 4 mg <1% 184 $834.18
84439 <1% 648 $797.93
83690 <1% 3,195 $786.77
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,826 $762.27
80061 Lipid panel <1% 3,656 $755.07
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 2,006 $734.40
99239 Hospital discharge day management, more than 30 minutes <1% 46 $692.83
86140 <1% 2,262 $626.32
99232 Hospital visit by a doctor, follow-up day <1% 96 $598.33
85379 <1% 981 $596.51
99203 Doctor's office visit, new patient (routine) <1% 98 $541.76
76641 <1% 24 $541.74
90715 <1% 13 $501.03
82570 <1% 1,033 $498.42
82962 <1% 2,205 $472.32
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 568 $388.98
J2550 Injection, promethazine hcl, up to 50 mg <1% 302 $378.34
85027 <1% 815 $372.66
94618 <1% 25 $372.40
81002 <1% 3,686 $363.09
74018 <1% 41 $322.67
87186 <1% 554 $314.94
87088 <1% 421 $312.49
87077 <1% 1,273 $309.79
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 289 $301.15
80306 <1% 1,969 $259.03
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 154 $248.59
81001 <1% 337 $235.84
76536 <1% 12 $228.70
73562 <1% 16 $218.40
82043 <1% 372 $208.90
85730 <1% 388 $203.13
J3010 Injection, fentanyl citrate, 0.1 mg <1% 126 $198.20
84481 <1% 78 $158.38
85652 <1% 742 $155.53
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 78 $148.14
97161 <1% 14 $128.63
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 283 $124.66
81003 <1% 302 $105.04
84100 <1% 132 $101.74
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,157 $90.33
92508 Group treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 425 $72.17
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 13 $71.23
81025 <1% 1,358 $62.18
84403 <1% 24 $54.94
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 611 $42.52
85008 <1% 712 $36.78
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 518 $34.36
J7120 Ringers lactate infusion, up to 1000 cc <1% 17 $34.22
A9270 Non-covered item or service <1% 757 $28.39
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 30 $26.26
86803 <1% 52 $24.67
77063 Screening digital breast tomosynthesis, bilateral <1% 135 $15.57
84311 <1% 50 $10.33
87081 <1% 269 $6.45
83986 <1% 49 $5.48
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 13 $5.16
84702 <1% 29 $4.06
84550 <1% 13 $0.53
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 128 $0.01
85007 0% 83 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 108 $0.00
97533 0% 33 $0.00
77080 0% 24 $0.00
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 0% 30 $0.00
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 0% 29 $0.00
87807 0% 26 $0.00
86901 0% 13 $0.00
82550 0% 13 $0.00
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 0% 30 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPARR, LYNETTE (CFO)